Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection

Science Daily - 1 Jul 2021 18:07
The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard